Drugs are approved — and made available — faster in US than most of EU, data show
New drugs in the US were, on average, approved months before winning approval in the EU, according to new data from The IQVIA Institute for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
